-+ 0.00%
-+ 0.00%
-+ 0.00%

CF PharmTech Wins NMPA Acceptance for Olopatadine and Mometasone Nasal Spray Clinical Trial Application

Reuters·12/17/2025 12:41:27

Please log in to view news